Meeting NewsVideo

VIDEO: Determination often required to obtain PCSK9 inhibitors for appropriate patients

BOSTON — In this video exclusive, Matthew Stryker, PharmD, a clinical pharmacist who runs a free cardiovascular risk reduction service at a clinic in Albany, New York, and is a stakeholder in The Doctor-Patient Rights Project, relates a personal story of seeking prior authorization for the PCSK9 inhibitor alirocumab for a statin-intolerant patient with familial hypercholesterolemia.

Only after a fourth appeal with a federal appeals judge was the patient able to obtain the medication. Stryker describes additional resources for prescribers in the appeals process after receiving denial of an original request.

 

BOSTON — In this video exclusive, Matthew Stryker, PharmD, a clinical pharmacist who runs a free cardiovascular risk reduction service at a clinic in Albany, New York, and is a stakeholder in The Doctor-Patient Rights Project, relates a personal story of seeking prior authorization for the PCSK9 inhibitor alirocumab for a statin-intolerant patient with familial hypercholesterolemia.

Only after a fourth appeal with a federal appeals judge was the patient able to obtain the medication. Stryker describes additional resources for prescribers in the appeals process after receiving denial of an original request.

 

    See more from Cardiometabolic Health Congress